|
Fluorine in PDB 8g1p: Co-Crystal Structure of Compound 11 in Complex with the Bromodomain of Human SMARCA2 and Pvhl:Elonginc:ElonginbProtein crystallography data
The structure of Co-Crystal Structure of Compound 11 in Complex with the Bromodomain of Human SMARCA2 and Pvhl:Elonginc:Elonginb, PDB code: 8g1p
was solved by
S.Ghimire Rijal,
R.P.Wurz,
A.Vaish,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Co-Crystal Structure of Compound 11 in Complex with the Bromodomain of Human SMARCA2 and Pvhl:Elonginc:Elonginb
(pdb code 8g1p). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the Co-Crystal Structure of Compound 11 in Complex with the Bromodomain of Human SMARCA2 and Pvhl:Elonginc:Elonginb, PDB code: 8g1p: Jump to Fluorine binding site number: 1; 2; Fluorine binding site 1 out of 2 in 8g1pGo back to Fluorine Binding Sites List in 8g1p
Fluorine binding site 1 out
of 2 in the Co-Crystal Structure of Compound 11 in Complex with the Bromodomain of Human SMARCA2 and Pvhl:Elonginc:Elonginb
Mono view Stereo pair view
Fluorine binding site 2 out of 2 in 8g1pGo back to Fluorine Binding Sites List in 8g1p
Fluorine binding site 2 out
of 2 in the Co-Crystal Structure of Compound 11 in Complex with the Bromodomain of Human SMARCA2 and Pvhl:Elonginc:Elonginb
Mono view Stereo pair view
Reference:
R.P.Wurz,
H.Rui,
K.Dellamaggiore,
S.Ghimire-Rijal,
K.Choi,
K.Smither,
A.Amegadzie,
N.Chen,
X.Li,
A.Banerjee,
Q.Chen,
D.Mohl,
A.Vaish.
Affinity and Cooperativity Modulate Ternary Complex Formation to Drive Targeted Protein Degradation. Nat Commun V. 14 4177 2023.
Page generated: Fri Aug 2 19:33:53 2024
ISSN: ESSN 2041-1723 PubMed: 37443112 DOI: 10.1038/S41467-023-39904-5 |
Last articlesZn in 9JPJZn in 9JP7 Zn in 9JPK Zn in 9JPL Zn in 9GN6 Zn in 9GN7 Zn in 9GKU Zn in 9GKW Zn in 9GKX Zn in 9GL0 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |